GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NRXP
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Friday for NRx Pharmaceuticals, Inc. stock after gaining 0.662%
(Updated on Apr 19, 2024)

Sell candidate since Apr 15, 2024 Loss -37.96% PDF

The NRx Pharmaceuticals, Inc. stock price gained 0.662% on the last trading day (Friday, 19th Apr 2024), rising from $3.02 to $3.04. During the last trading day the stock fluctuated 8.00% from a day low at $3.00 to a day high of $3.24. The price has fallen in 7 of the last 10 days and is down by -42.64% for this period. Volume fell on the last day by -531 thousand shares and in total, 232 thousand shares were bought and sold for approximately $705.11 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $3.03 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 12.90% during the next 3 months and, with a 90% probability hold a price between $3.43 and $8.39 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NRXP Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 0.662%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The NRx Pharmaceuticals, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.29 and $5.09. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for NRx Pharmaceuticals, Inc. stock

NRx Pharmaceuticals, Inc. finds support from accumulated volume at $3.02 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.240 between high and low, or 8.00%. For the last week the stock has had daily average volatility of 7.90%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NRXP) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect NRx Pharmaceuticals, Inc. to open at $3.09, and during the day (based on 14 day Average True Range), to move between $2.40 and $3.68, which gives a possible trading interval of +/-$0.645 (+/-21.21%) up or down from last closing price. If NRx Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 42.41% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $3.05 (0.26%) than the support at $3.02 (0.66%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is NRx Pharmaceuticals, Inc. stock A Buy?

The NRx Pharmaceuticals, Inc. stock holds several negative signals and despite the positive trend, we believe NRx Pharmaceuticals, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.813 Sell Candidate Unchanged

Predicted Opening Price for NRx Pharmaceuticals, Inc. of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$3.09 ( 1.75%) $3.04

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NRXP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.33 9.65 %
R2 3.24 6.63 %
R1 3.19 4.77 %
Current price: 3.04
Support S1 3.00 -1.26 %
S2 2.95 -3.12 %
S3 2.85 -6.14 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.70 21.71 %
R2 3.59 18.09 %
R1 3.05 0.263 %
Current price 3.04
Support S1 3.02 -0.658%
S2 2.94 -3.29%
S3 0 .

FAQ

What is the symbol for NRx Pharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for NRx Pharmaceuticals, Inc. is NRXP and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell NRx Pharmaceuticals, Inc. Stock?
The NRx Pharmaceuticals, Inc. stock holds several negative signals and despite the positive trend, we believe NRx Pharmaceuticals, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy NRx Pharmaceuticals, Inc. Stock?
NRx Pharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy NRx Pharmaceuticals, Inc. Stock.

What's the current price of NRx Pharmaceuticals, Inc. Stock?
As of the end of day on the 2024-04-19, the price of an NRx Pharmaceuticals, Inc. (NRXP) share was $3.04.

What is the 52-week high and low for NRx Pharmaceuticals, Inc. Stock?
The 52-week high for NRx Pharmaceuticals, Inc. Stock is $12.00 and the 52-week low is $2.21.

What is the market capitalization of NRx Pharmaceuticals, Inc. Stock?
As of the 2024-04-19, the market capitalization of NRx Pharmaceuticals, Inc. is 29.093M.

When is the next earnings date for NRx Pharmaceuticals, Inc.?
The upcoming earnings date for NRx Pharmaceuticals, Inc. is May 21, 2024.
Click to get the best stock tips daily for free!

About NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals. NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal... NRXP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT